key: cord-0966009-sw5ribpt
authors: Wang, F.; Huang, S.; Gao, H.; Zhou, Y.; Lai, C.; Li, Z.; Xian, W.; Qian, X.; Huang, Y.; Tang, Q.; Liu, P.; Chen, R.; Liu, R.; Li, X.; Xin, T.; Xuan, Z.; Bai, Y.; Duan, G.; Zhang, T.; Xu, X.; Wang, J.; Yang, H.; Liu, S.; He, Q.; Jin, X.; Liu, L.
title: Initial Study of Human Genetic Contribution to COVID-19 Severity and Susceptibility
date: 2020-06-11
journal: nan
DOI: 10.1101/2020.06.09.20126607
sha: 15df97e86eac33c66d70f2ab6348018e75ff0008
doc_id: 966009
cord_uid: sw5ribpt

The COVID-19 pandemic has accounted for more than five million infections and hundreds of thousand deaths worldwide in the past six months. The patients demonstrate a great diversity in clinical and laboratory manifestations and disease severity. Nonetheless, little is known about the host genetic contribution to the observed inter-individual phenotypic variability. Here, we report the first host genetic study in China by deeply sequencing and analyzing the 332 COVID-19 patients categorized by varying levels of severity from the Shenzhen Third People's Hospital. Based on a total of 22.2 million genetic variants, we conducted both single-variant and gene-based association tests among the five severity groups including asymptomatic, mild, moderate, severe and critical ill patients after the correction of potential confounding factors. The most significant gene loci associated with severity is located in TMEM189-UBE2V1 involved in the IL-1 signaling pathway. The p.Val197Met missense variant that affects the stability of the TMPRSS2 protein displays a decreasing allele frequency among the severe patients compared to the mild and the general population. We also identified that the HLA-A*11:01, B*51:01 and C*14:02 alleles significantly predispose the worst outcome of the patients. This initial study of Chinese patients provides a comprehensive view of the genetic difference among the COVID-19 patient groups and highlighted genes and variants that may help guide targeted efforts in containing the outbreak. Limitations and advantages of the study was also reviewed to guide future international efforts on elucidating the genetic architecture of host-pathogen interaction for COVID-19 and other infectious and complex diseases.

It has been more than 100 years since the 1918 influenza outbreak killed at 54 least fifty million people worldwide 1 . Now we are facing another pandemic.

Since the late December of 2019, the 2019 novel coronavirus diseases 56 (COVID-19) has spread rapidly throughout the world, resulting in more than five 57 million confirmed cases and hundreds of thousands deaths in less than six 58 months 2,3 . The disease was caused by the infection of a novel enveloped RNA 59 betacoronavirus that has been named severe acute respiratory syndrome 60 coronavirus 2 (SARS-CoV-2), which is the seventh coronavirus species that 61 causes respiratory disease in humans 4,5 . The virus causes serious respiratory 62 illnesses such as pneumonia, lung failure and even death 6 . Until now, there is 63 no specific therapeutics and vaccine available for its control. Continuing 64 epidemiological and molecular biological study to better understand, treat and respiratory failure [8] [9] [10] [11] . Patients with severe disease had more prominent 74 laboratory abnormalities including lymphocytopenia and leukopenia than those 75 with non-severe disease 12,13 . In addition, not all people exposed to SARS-CoV- Genome-wide association test on array data from the UK Biobank participants 98 with a positive and negative PCR-tests also reveals a few suggestive genes 27 .

The COVID-19 host genetics initiative was established to encourage generation, 

Clinical and laboratory features of the 332 hospitalized COVID-19 patients 132

The 332 recruited patients with laboratory-confirmation of SARS-COV-2 133 infection were being quarantined and treated in the Shenzhen Third Hospital.

We extracted and analyzed the clinical symptoms, laboratory assessment, 

The patients' clinical presentations mainly involve fever (70.8%), cough 153 (54.2%), fatigue (23.9%), hoarse voice (17.6%), loss of appetite (16.2%), 154 delirium (15.1%) and less than 10% had experienced diarrhea, chest and 155 abdominal pain, shortness of breath and anosmia ( Figure S1 ). More than 156 50% of the patients have at least one medical comorbidities (e.g.,

hypertension). Consistent with previous report, the broadly defined severe 158 patients tend to be older (severe average 45 years old vs mild average 58 159 years old, t-test p=0.03， Figure 1C) , a longer disease duration (period of 160 time between disease onset and the first negative PCR-test, Figure 1D ) and 161 shorter exposure time (Figure S2 ) , consist of more males than females 162 (severe 66.7% vs mild 41.3%, χ 2 test p=4.3e-4, Figure 1E ) and tend to 163 undergo medical comorbidities more frequently (severe 58.8% vs mild 45.1%, 164 χ 2 test p=0.07) ( Figure 1F ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. Table S1 . 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 11, 2020. . https://doi.org/10.1101/2020.06.09.20126607 doi: medRxiv preprint time duration between the complained disease onset and the first laboratory 258 confirmed PCR-test negative outcome (N=233) ( Figure 1D ). Power analysis 259 indicates that given 80% statistical power, we will be able to identify 260 associations between genotypes and phenotypes for variants with minor allele 261 frequency greater than 0.2 and with a relative genetic risk contribution greater 262 than 2 given the current sample size for dichotomous trait and similarly for the 263 quantitative trait ( Figure S12) . Principal component analysis of the patients 264 suggests little genetic differentiation (Figure S13-14) .

We tested all the QC-passed 19.6 million bi-allelic variants for 266 association with each of three traits in a logistic or linear regression model that all the sixty-four laboratory assessments among the patients (Figure 4C ).

Therefore, the observed signal is not supposed to be confounded by individual 300 variability on blood cell types. There is no strong genetic association with the 301 disease durations ( Figure 3C ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 11, 2020. . https://doi.org/10.1101/2020.06.09.20126607 doi: medRxiv preprint

We further perform optimal SKAT gene-based association test on the 303 functional variants including a total of 99,166 missense and loss of function 304 variants that were predicted to have high or moderate impacts by variant effect 305 predictor among the patients. The NOA1 gene tend to higher mutation burden 306 in the severe group (P= 8.1e-07) ( Figure 3D ). This gene encodes the GTPase 307 that functions in the mitochondrion and has been associated with platelet count 308 and leukocyte count 45 . We didn't identify other genes that are genome-wide between people who are exposed or not exposed to the pathogen. This is CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 11, 2020. . https://doi.org/10.1101/2020.06.09.20126607 doi: medRxiv preprint ( Figure 6A ) even though the inflation was seemingly adequately controlled 395 ( Figure S19 ). In the gene-based association test, we observed significantly 396 different mutation burdens in the immunoglobulin loci ( Figure 6B) . However, 397 this is not replicated when we compared the COVID-19 patients with the 665 398 CNRP individuals (Figure 6C-D) . Therefore, we inferred that the association 399 signals between the 1KGP and the COVID-19 patients were probably due to 

In the single variant association test between the COVID-19 patients and 407 the CNPR who were sequenced using the same experimental protocol and 408 were laboratory PCR tested negative, we identified genome-wide significant 

We revealed that the disease progression after the SARS-CoV-2 434 infection is a complex event rather than be explained by a monogenic model.

The severe and critical patients do not carry causal monogenic variants related is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 11, 2020. . globe, it will be important to identify and study the extreme asymptomatic 487 patients to understand the host factors contributing to a good control of the viral 488 infection.

As we and the others are continuing to recruit patients and data in China 

This work is also an initial start to guide study design regarding the selection of 497 samples, the genetic assay approach, the bioinformatics and the statistical 498 genetic analysis for COVID-19 as well as other infection and complex disease.

The publicly available summary statistics will encourage international 500 collaborative efforts to understand the host-pathogen interaction and to contain 501 the COVID-19 outbreak. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 11, 2020. . https://doi.org/10.1101/2020.06.09.20126607 doi: medRxiv preprint COVID19 in China and the Chinese CDC criteria 6 , the patients were diagnosed 533 as asymptomatic, mild, moderate, severe and critically severe according to the 534 most severe stage they experienced during the disease course. The 535 asymptomatic, mild and the moderate groups of patients do not experience 536 pneumonia. When meeting any one of the following criteria, 1) RR>30 2)

Oxygen level < 93% 3) PaO2/FiO2 < 300 mmHg 4) disease progression greater 538 than 50% area in CT scan, a patient is categorized as severe patients. Patients 

Genotype-phenotype association analysis

We have applied both the rvtest 70 and the SAIGE 71 approaches to carry out is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 11, 2020. .

between the 1KGP and the COVID-19 patients as age is not available for the 626 1KGP data set. Independent loci were defined as significant variants clustered 627 in a 1Mbp window. The lead SNP was defined as the SNP in the 1Mbp window 628 that has most significant, i.e., smallest p value. The genomic inflation factor, GC 629 lambda, attenuation ratio, LD score regression intercept and the SNP heritability 630 were estimated using the LD score regression approach 72 . The qqman R 631 package was applied to generate the manhattan and qqplot. We defined 632 genome-wide significance for single variant association test as 5e-8, suggestive 633 significance as 1e-5 and for gene-based association test as 1e-6. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. . https://doi.org/10.1101/2020.06.09.20126607 doi: medRxiv preprint variant genome-wide association test for the sixty-four laboratory assessments at the 924 lead SNP rs6020298. The P-value of the three traits (Severity, Severity score and 925

Disease Duration) in Figure 3 were also displayed. 926 927 928 929 930 931 932 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 11, 2020. . https://doi.org/10.1101/2020.06.09.20126607 doi: medRxiv preprint

Updating the accounts: global mortality of 655 the 1918-1920 'Spanish' influenza pandemic

A novel coronavirus from patients with pneumonia in China

An emerging coronavirus causing pneumonia 663 outbreak in Wuhan, China: calling for developing therapeutic and prophylactic 664 strategies. Emerging Microbes and Infections

A review of studies on animal reservoirs of the SARS 667 coronavirus

Characteristics of and Important Lessons From the 669

COVID-19) Outbreak in China

Human Genetic Determinants of Viral Diseases

Clinical characteristics of coronavirus disease 2019 in China

Clinical characteristics of coronavirus disease 2019 (COVID-19) in 676 China: A systematic review and meta-analysis

The epidemiological characteristics of an outbreak of 2019 novel coronavirus 681 diseases (COVID-19) in China

Dysregulation of immune response in patients with COVID-19 in 684

Clinical course and outcomes of critically ill patients with SARS-686

CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, 687 observational study

Backcalculating the Incidence of Infection with COVID-19 on the 690 Diamond Princess

Clinical characteristics of 24 asymptomatic infections with COVID-692 19 screened among close contacts in Nanjing

Common genetic variation and the control of HIV-1 in humans

A whole-genome association study of major determinants for 697 host control of HIV-1. Science (80-. )

A genome-wide association study identifies variants in the 702 HLA-DP locus associated with chronic hepatitis B in Asians

Genetic variation in IL28B predicts hepatitis C treatment-induced 705 viral clearance

Whole-exome sequencing reveals mutations in genes 707 linked to hemophagocytic lymphohistiocytosis and macrophage activation 708 syndrome in fatal cases of H1N1 influenza

Early hypercytokinemia is associated with interferon-induced 711 transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection

IFITM3 restricts the morbidity and mortality associated with 714 influenza

Interferon-inducible transmembrane protein 3 genetic variant 716 rs12252 and influenza susceptibility and severity: A meta-analysis

Association of HLA class I with severe acute respiratory 719 syndrome coronavirus infection

Significance of the Myxovirus Resistance A (MxA)

Nucleotide Polymorphism in Suppressed Interferon β 723 Induction of Severe Acute Respiratory Syndrome Coronavirus Infection

The landscape of host genetic factors involved in infection to 726 common viruses and SARS-CoV-2. medRxiv (2020)

Self-reported symptoms of covid-19 including symptoms 729 most predictive of SARS-CoV-2 infection, are heritable. medRxiv (2020)

Relationship between the ABO Blood Group and the COVID-19

Comparative genetic analysis of the novel coronavirus (2019-734 nCoV/SARS-CoV-2) receptor ACE2 in different populations

Global Spread of SARS-CoV-2 Subtype with Spike 737 Protein Mutation D614G is Shaped by Human Genomic Variations that 738 Regulate Expression of TMPRSS2 and MX1 Genes

ACE2 variants underlie interindividual variability and 741 susceptibility to COVID-19 in Italian population. medRxiv (2020)

The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role 744 of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus 745 pandemic

COVID-19 in a designated infectious diseases hospital outside 747

Genetic predisposition models to COVID-19 750 infection

A global reference for human genetic variation

From local explanations to global understanding with 754 explainable AI for trees

Towards an Artificial Intelligence Framework for Data-Driven 757 Prediction of Coronavirus Clinical Severity

A framework for variation discovery and genotyping using 760 next-generation DNA sequencing data

The Ensembl Variant Effect Predictor

Variation across 141,456 human exomes and genomes 764 reveals the spectrum of loss-of-function intolerance across human protein-765 coding genes

An open resource of structural variation for medical and 767 population genetics

Whole-exome sequencing identifies MST1R as a genetic 769 susceptibility gene in nasopharyngeal carcinoma

ACE2 Homo-dimerization, Human Genomic variants and 772 Interaction of Host Proteins Explain High Population Specific Differences in 773 Outcomes of COVID19. bioRxiv

The GeneCards suite: From gene data mining to disease 775 genome sequence analyses

TRIM5 is an innate immune sensor for the retrovirus capsid 778 lattice

COVID-19 infection: the perspectives on immune responses

Interleukin-1 blockade with high-dose anakinra in patients with 782 COVID-19, acute respiratory distress syndrome, and hyperinflammation: a 783 retrospective cohort study

The NHGRI-EBI GWAS Catalog of published genome-wide 786 association studies, targeted arrays and summary statistics 2019

Amino acid variation in HLA class II proteins is a major 789 determinant of humoral response to common viruses

Genome-wide association and HLA region fine-mapping studies 792 identify susceptibility loci for multiple common infections

Fast and accurate HLA typing from short-read next-generation 795 sequence data with xHLA

An Integrated Tool to Study MHC Region: Accurate SNV 798 Detection and HLA Genes Typing in Human MHC Region Using Targeted 799 High-Throughput Sequencing

Allele frequency net database

Human leukocyte antigen susceptibility map for SARS-CoV-804

Optimal sequencing 810 strategies for identifying disease-associated singletons

Recovery of trait heritability from whole genome 813 sequence data

Is Behçet's disease a 'class 1-818 opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease. 819

XGBoost: A scalable tree boosting system

Missforest-Non-parametric missing value 827 imputation for mixed-type data

Ordinal regression by extended binary classification

A unified approach to interpreting model 833 predictions

Genomics Tools -A fast and accurate solution to variant calling from next-836 generation sequence data

Second-generation PLINK: rising to the challenge of larger 838 and richer datasets

RVTESTS: An efficient 842 and comprehensive tool for rare variant association analysis using sequence 843 data

Efficiently controlling for case-control imbalance and sample 845 relatedness in large-scale genetic association studies